ES8404686A1 - Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico. - Google Patents

Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.

Info

Publication number
ES8404686A1
ES8404686A1 ES521359A ES521359A ES8404686A1 ES 8404686 A1 ES8404686 A1 ES 8404686A1 ES 521359 A ES521359 A ES 521359A ES 521359 A ES521359 A ES 521359A ES 8404686 A1 ES8404686 A1 ES 8404686A1
Authority
ES
Spain
Prior art keywords
formula
procedure
carboxylic acid
ester compounds
ciproheptadin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521359A
Other languages
English (en)
Other versions
ES521359A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES521359A0 publication Critical patent/ES521359A0/es
Publication of ES8404686A1 publication Critical patent/ES8404686A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS ESTERES DEL ACIDO CIPROHEPTADIN-3-CARBOXILICO Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X, R, R Y R PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO DE FORMULA Y-CH2-R, EN LAS QUE Y ES CLORO, BROMO O YODO, Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UN ACEPTOR DE ACIDO, TAL COMO UNA BASE ORGANICA FUERTE O UNA BASE INORGANICA, A UNA TEMPERATURAENTRE 5JC Y 100JC.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA EMESIS.
ES521359A 1982-04-14 1983-04-11 Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico. Expired ES8404686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/368,257 US4412999A (en) 1982-04-14 1982-04-14 Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds

Publications (2)

Publication Number Publication Date
ES521359A0 ES521359A0 (es) 1984-05-16
ES8404686A1 true ES8404686A1 (es) 1984-05-16

Family

ID=23450498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521359A Expired ES8404686A1 (es) 1982-04-14 1983-04-11 Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.

Country Status (16)

Country Link
US (1) US4412999A (es)
EP (1) EP0092114B1 (es)
JP (1) JPS58188879A (es)
KR (1) KR880002042B1 (es)
AT (1) ATE30589T1 (es)
AU (1) AU556530B2 (es)
CA (1) CA1203798A (es)
DE (1) DE3374312D1 (es)
DK (1) DK161983A (es)
ES (1) ES8404686A1 (es)
GR (1) GR78832B (es)
IE (1) IE55033B1 (es)
IL (1) IL68306A (es)
NZ (1) NZ203786A (es)
PT (1) PT76501B (es)
ZA (1) ZA832589B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522821A (en) * 1982-04-14 1985-06-11 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
CA2025398A1 (en) * 1989-09-20 1992-03-15 Timothy Gerard Dinan Diagnosis and treatment of a disorder of the gastrointestinal tract
FR2877573B1 (fr) * 2004-11-05 2007-02-02 Debussy Holding Sa Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
EP2067777B1 (en) 2006-09-29 2013-08-14 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
CN104884064A (zh) 2012-12-24 2015-09-02 纽洛佳斯特拉斯公司 用于治疗胃肠道病症的方法
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014911A (en) * 1958-09-29 1961-12-26 Merck & Co Inc Derivatives of dibenzo[a, e]cycloheptatriene
NL125839C (es) * 1963-12-03
US3981877A (en) * 1972-08-14 1976-09-21 Merck & Co., Inc. Piperidylidene derivatives of carboxy-5H-dibenzo[a,d]cycloheptene
US4072756A (en) * 1973-05-17 1978-02-07 Sandoz Ltd. Tricyclo piperidino ketones and soporific compositions thereof
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
NL173398C (nl) * 1974-11-11 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten alsmede werkwijze ter bereiding van een aan een benzeenkern gesubstitueerd 1-methyl-4-(10,11-dihydro-5h-dibenzo (a,d)cyclohepten-5-ylideen)-piperidinederivaat.
US4076714A (en) * 1974-11-25 1978-02-28 Merck & Co., Inc. 1-Methyl-4-(2-carboxy-thioxanthen-9-ylidene)-piperidine an appetite stimulant and antihistaminic agent
US4160031A (en) * 1975-03-28 1979-07-03 Merck & Co., Inc. Antihistaminic and appetite stimulating 10,11-dihydro-3-carboxycyproheptadine
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds

Also Published As

Publication number Publication date
DE3374312D1 (en) 1987-12-10
IE55033B1 (en) 1990-05-09
CA1203798A (en) 1986-04-29
EP0092114A2 (en) 1983-10-26
ZA832589B (en) 1984-11-28
EP0092114A3 (en) 1985-01-16
JPS58188879A (ja) 1983-11-04
AU556530B2 (en) 1986-11-06
ES521359A0 (es) 1984-05-16
KR880002042B1 (ko) 1988-10-13
PT76501B (en) 1986-02-06
AU1318883A (en) 1983-10-20
US4412999A (en) 1983-11-01
DK161983A (da) 1983-10-15
ATE30589T1 (de) 1987-11-15
DK161983D0 (da) 1983-04-13
EP0092114B1 (en) 1987-11-04
NZ203786A (en) 1985-11-08
PT76501A (en) 1983-05-01
IE830833L (en) 1983-10-14
GR78832B (es) 1984-10-02
IL68306A0 (en) 1983-07-31
IL68306A (en) 1986-09-30
KR840004422A (ko) 1984-10-15

Similar Documents

Publication Publication Date Title
ES8303383A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
ES8307804A1 (es) Un procedimiento para la preparacion de hidantoinas.
ES8300692A1 (es) Un procedimiento para la preparacion de derivados de acido carbamico
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8307202A1 (es) "procedimiento para preparar un acido alcanoico substituido en posicion alfa con un grupo aromatico, opticamente activo".
ES8401034A1 (es) Derivados de quinolina.
ES8205408A1 (es) Un procedimiento de preparacion de compuestos intermedios para la produccion de picropodofilina.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8300756A1 (es) Un procedimiento para la preparacion de una isoxazolilimida-zolidinona
ES8401079A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2-amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido)-3-cefem-4-carboxilico.
ES8304976A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8201940A1 (es) Un procedimiento para preparar derivados de esteres de aci- dos ciclopropanocarboxilicos
ES8601211A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ES8300741A1 (es) Un procedimiento para la preparacion de tiofen-sulfonamidas con actividad insecticida.
ES8200883A1 (es) Un metodo de preparar derivados de fenil-piperazina farma- ceuticamente activos
ES8200355A1 (es) Un procedimiento para la preparacion de compuestos heteroci-clicos
ES8402310A1 (es) Un procedimiento para la preparacion de agentes antibacterianos unidos de dicarboxilato de 1,1-alcanodiol.
ES8401485A1 (es) Un procedimiento de preparacion de nuevas 8-(3-(1,2-bencisoxazol-3-il)propil)-1-fenil-1,3,8-triazaspiro(4,5)decan-4-onas.
ES8204410A1 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
ES8406431A1 (es) Procedimiento para preparar derivados de pleuromutilina
ES8705463A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida